4.7 Article

Converging PET and fMRI evidence for a common area involved in human focal epilepsies

Journal

NEUROLOGY
Volume 77, Issue 9, Pages 904-910

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31822c90f2

Keywords

-

Funding

  1. Deutsche Forschungsgemeinschaft [LA 1452/3-1]
  2. Bundesministerium fur Bildung und Forschung [01 EV 0703]
  3. Medical Research Council UK [G0301067]
  4. University College London Hospital NHS Trust
  5. Wellcome Trust
  6. National Society for Epilepsy
  7. Department of Health's NIHR Biomedical Research Centre
  8. Wellcome Department for Cognitive Neuroscience
  9. Brain
  10. Institute of Neurology, UCL, UK
  11. UCB
  12. Eisai Inc.
  13. Janssen
  14. Medical Research Council UK
  15. NIH
  16. BIAL
  17. Medical Research Council
  18. Action Medical Research
  19. Brain Research Trust
  20. Higher Education Funding Council
  21. GlaxoSmithKline
  22. Grunenthal GmbH
  23. EU
  24. Pfizer Inc
  25. Desitin Pharmaceuticals, GmbH
  26. MRC
  27. Wellcome Trust Foundation
  28. MRC [G0301067] Funding Source: UKRI
  29. Medical Research Council [G0200216, G0301067] Funding Source: researchfish
  30. National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish

Ask authors/readers for more resources

Objectives: Experiments in animal models have identified specific subcortical anatomic circuits, which are critically involved in the pathogenesis and control of seizure activity. However, whether such anatomic substrates also exist in human epilepsy is not known. Methods: We studied 2 separate groups of patients with focal epilepsies arising from any cortical location using either simultaneous EEG-fMRI (n = 19 patients) or [C-11]flumazenil PET (n = 18). Results: Time-locked with the interictal epileptiform discharges, we found significant hemodynamic increases common to all patients near the frontal piriform cortex ipsilateral to the presumed cortical focus. GABA(A) receptor binding in the same area was reduced in patients with more frequent seizures. Conclusions: Our findings of cerebral blood flow and GABAergic changes, irrespective of where interictal or ictal activity occurs in the cortex, suggest that this area of the human primary olfactory cortex may be an attractive new target for epilepsy therapy, including neurosurgery, electrical stimulation, and focal drug delivery. Neurology (R) 2011;77:904-910

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available